StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from a hold rating to a buy rating in a research note released on Tuesday. A number of other analysts have also recently ...
The speculation comes as Dentsply ( NASDAQ: XRAY) said Tuesday it started a process to evaluate strategic alternatives for ...
Hosted on MSN4d
Wells Fargo Initiates Coverage of DENTSPLY SIRONA (XRAY) with Equal-Weight RecommendationFintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a ...
Wells Fargo (NYSE:WFC) began coverage on DENTSPLY SIRONA (NASDAQ: NASDAQ:XRAY) shares, assigning an Equal Weight rating and setting a price target of $20.00. The new rating comes as DENTSPLY SIRONA's ...
Wells Fargo initiated coverage of Dentsply Sirona (XRAY) with an Equal Weight rating and $20 price target The firm does not sees a “clean ...
CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate ...
Dentsply Sirona announced that it initiated a process to evaluate strategic alternatives for its Wellspect Healthcare ...
Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect, a provider of bladder and bowel management care products, has an estimated $2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback